• SENSEX
    NIFTY 50
Healthcare

COVID-19 cure: Glenmark says faster time to clinical recovery with Favipiravir

Updated : July 23, 2020 07:25 AM IST

About 70 percent of patients being treated by FabiFlu along with standard supportive care achieved 'clinical cure' by the fourth day of the study.
Indian drug controller had approved Favipiravir for 'restricted emergency use' for treatment for mild to moderate patients, even while the phase 3 clinical trials were still ongoing.
COVID-19 cure: Glenmark says faster time to clinical recovery with Favipiravir

You May Also Like

Live TV
Advertisement